TAPENTADOL NASAL SPRAY FOR PAIN CONTROL POST EXTRACTIO
Phase 2
- Conditions
- Health Condition 1: K041- Necrosis of pulp
- Registration Number
- CTRI/2022/07/043654
- Lead Sponsor
- MD KHIZAR HUSSAIN MAZHARI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
PATIENT REQUIRING BILATERAL EXTRACTION CASES WILL BE CHOSEN UP FOR THE STUDY.
PATIENTS BETWEEN AGE GROUP OF 15-50 WILL BE TAKEN UP FOR THE STUDY.
PATIENTS WHO ARE MEDICALLY FIT WOULD BE TAKEN UP FOR THE STUDY
Exclusion Criteria
PATIENT ALLERGIC TO DRUGS WIIL BE EXCLUDED.
PATIENTS, WHO REQUIRE TRAUMATIC EXTRACTIONS, AND PATIENT WITH ANY UNDERLYING PATHOLOGY WILL BE SPARED.
PATIENTS WHO HAVE HISTORY OF NASAL PATHOLOGY VIZ RHINITIS, POLYPS, DEVIATED NASAL SEPTUM WOULD BE SPARED
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method